Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 23, 2019 07:30 ET | Source: Nemus Bioscience, Inc.

Nemus Bioscience to Present at the NobleCon XV and 8th Annual Glaucoma 360 New Horizons Forum

LONG BEACH, CA, Jan. 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nemus Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to...
January 03, 2019 07:00 ET | Source: Nemus Bioscience, Inc.

Nemus Bioscience to Present at the 2nd Annual Sach’s Neuroscience Innovation Forum and Biotech Showcase 2019

LONG BEACH, CA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nemus Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to...
November 29, 2018 15:51 ET | Source: Nemus Bioscience, Inc.

Nemus Bioscience to Present at Investment and Scientific Conferences in December

Long Beach, CA, Nov. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nemus Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to...
October 15, 2018 08:30 ET | Source: Nemus Bioscience, Inc.

Nemus Bioscience to Present at BIO Investor Forum

LONG BEACH, CA, Oct. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical...
October 08, 2018 08:00 ET | Source: Nemus Bioscience, Inc.

Nemus Bioscience Announces that Emerald Health Sciences has Provided a Credit Facility of up to $20 Million and Adopted an Open Market Share Purchase Program of up to 10 Million Common Shares

Avtar Dhillon, MD, appointed as Executive Chairman of Nemus LONG BEACH, CA, Oct. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the...
September 26, 2018 08:00 ET | Source: Nemus Bioscience, Inc.

NEMUS Bioscience to Present at The MicroCap Conference

LONG BEACH, CA, Sept. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - NEMUS Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical...
August 28, 2018 08:00 ET | Source: Nemus Bioscience, Inc.

NEMUS Bioscience to Present at the Rodman & Renshaw 20th Annual Global Investment Conference

Long Beach, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- NEMUS Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical...
August 01, 2018 09:54 ET | Source: Nemus Bioscience, Inc.

UPDATE: Nemus Bioscience, Inc. Signs Agreement with Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredient for Glaucoma

Long Beach, CA, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially...
August 01, 2018 08:30 ET | Source: Nemus Bioscience, Inc.

Nemus Bioscience, Inc. Signs Agreement with Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredient for Glaucoma

Long Beach, Calif., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications,...
May 30, 2018 08:30 ET | Source: Nemus Bioscience, Inc.

Nemus Bioscience to Participate at the 8th Annual LD Micro Invitational

LONG BEACH, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications,...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right